Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water

被引:121
作者
Andrew, AS
Karagas, MR
Hamilton, JW
机构
[1] Dartmouth Coll Sch Med, Dept Community & Family Med, Lebanon, NH 03756 USA
[2] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03756 USA
[3] Dartmouth Coll Sch Med, Norris Cotton Canc Ctr, Lebanon, NH USA
关键词
nucleotide excision repair; ERCC1; XPF; XPG; arsenic; DNA repair; molecular epidemiology; lymphocytes;
D O I
10.1002/ijc.10968
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Arsenic is well established as a human carcinogen, but its precise mechanism of action remains unknown. Arsenic does not directly damage DNA, but may act as a carcinogen through inhibition of DNA repair mechanisms, leading indirectly to increased mutations from other DNA damaging agents. The molecular mechanism underlying arsenic inhibition, of nucleotide excision repair after UV irradiation (Hartwig et al., Carcinogenesis 1997;18:399-405) is unknown, but could be due to decreased expression of critical genes involved in nucleotide excision repair of damaged DNA. This hypothesis was tested by analyzing expression of repair genes and arsenic exposure in a subset of 16 individuals enrolled in a population based case-control study investigating arsenic exposure and cancer risk in New Hampshire. Toenail arsenic levels were inversely correlated with expression of critical members of the nucleotide excision repair complex, ERCCI (r(2) = 0.82, p < 0.0001), XPF (r(2) = 0.56, p < 0.002), and XPB (r(2) = 0.75, p < 0.0001). The internal dose marker, toenail arsenic level, was more strongly associated with changes in expression of these genes than drinking water arsenic concentration. Our findings, based on human exposure to arsenic in a US population, show an association between biomarkers of arsenic exposure and expression of DNA repair genes. Although our findings need verification in a larger study group, they are consistent with the hypothesis that inhibition of DNA repair capacity is a potential mechanism for the co-carcinogenic activity of arsenic. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 45 条
  • [1] Arsenic: Health effects, mechanisms of actions, and research issues
    Abernathy, CO
    Liu, YP
    Longfellow, D
    Aposhian, HV
    Beck, B
    Fowler, B
    Goyer, R
    Menzer, R
    Rossman, T
    Thompson, C
    Waalkes, M
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 (07) : 593 - 597
  • [2] [Anonymous], 2001, Arsenic in Drinking Water
  • [3] Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks
    Araujo, FD
    Pierce, AJ
    Stark, JM
    Jasin, M
    [J]. ONCOGENE, 2002, 21 (26) : 4176 - 4180
  • [4] Protein complexes in nucleotide excision repair
    Araújo, SJ
    Wood, RD
    [J]. MUTATION RESEARCH-DNA REPAIR, 1999, 435 (01): : 23 - 33
  • [5] Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways
    Barchowsky, A
    Roussel, RR
    Klei, LR
    James, PE
    Ganju, N
    Smith, KR
    Dudek, EJ
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 159 (01) : 65 - 75
  • [6] Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells
    Barchowsky, A
    Dudek, EJ
    Treadwell, MD
    Wetterharn, KE
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1996, 21 (06) : 783 - 790
  • [7] CASE-CONTROL STUDY OF BLADDER-CANCER AND ARSENIC IN DRINKING-WATER
    BATES, MN
    SMITH, AH
    CANTOR, KP
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (06) : 523 - 530
  • [8] Expression of p53 in arsenic-related and sporadic basal cell carcinoma
    Boonchai, W
    Walsh, M
    Cummings, M
    Chenevix-Trench, G
    [J]. ARCHIVES OF DERMATOLOGY, 2000, 136 (02) : 195 - 198
  • [9] Molecular genetics of cancer susceptibility
    Brockmöller, J
    Cascorbi, I
    Henning, S
    Meisel, C
    Roots, I
    [J]. PHARMACOLOGY, 2000, 61 (03) : 212 - 227
  • [10] Chen H, 2001, MOL CARCINOGEN, V30, P79, DOI 10.1002/1098-2744(200102)30:2<79::AID-MC1016>3.0.CO